GSA Capital Partners’s ProQR Therapeutics PRQR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-14,683
| Closed | -$20K | – | 2071 |
|
|
2025
Q1 | $20K | Buy |
+14,683
| New | +$20K | ﹤0.01% | 1585 |
|
|
2023
Q4 | – | Sell |
-74,084
| Closed | -$96K | – | 1837 |
|
|
2023
Q3 | $96K | Buy |
74,084
+30,248
| +69% | +$39.2K | 0.01% | 1392 |
|
|
2023
Q2 | $71K | Buy |
+43,836
| New | +$71K | 0.01% | 1402 |
|
|
2023
Q1 | – | Sell |
-21,514
| Closed | -$80K | – | 1846 |
|
|
2022
Q4 | $80K | Buy |
+21,514
| New | +$80K | 0.01% | 1329 |
|
|
2021
Q4 | – | Sell |
-137,003
| Closed | -$1.15M | – | 1719 |
|
|
2021
Q3 | $1.15M | Buy |
137,003
+75,714
| +124% | +$634K | 0.12% | 239 |
|
|
2021
Q2 | $413K | Buy |
61,289
+35,137
| +134% | +$237K | 0.05% | 753 |
|
|
2021
Q1 | $173K | Sell |
26,152
-21,473
| -45% | -$142K | 0.03% | 936 |
|
|
2020
Q4 | $200K | Buy |
+47,625
| New | +$200K | 0.03% | 994 |
|
|
2019
Q4 | – | Sell |
-11,231
| Closed | -$65K | – | 1665 |
|
|
2019
Q3 | $65K | Buy |
+11,231
| New | +$65K | 0.01% | 1302 |
|